Saturday, July 11, 2026

biotech

Huabo Biopharm Co

Huabo Biopharm Co is a biotech organization headquartered in CN. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO so

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
0
Patents
0
Clinical program

HB0017

Phase 1 · small molecule · Healthy Subjects

HB0017 for Healthy Subjects is a Phase 1 program (small_molecule) at Huabo Biopharm Co., with 1 ClinicalTrials.gov record(s).

← All Huabo Biopharm Co., projects Phase 1 small molecule completed

Internal code HB0017-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Huabo Biopharm Co.,
Phase
Phase 1
Modality
small_molecule
Indication
Healthy Subjects
Status
completed
Trials
1

Clinical trials